Plaquenil (hydroxychloroquine screening)
Hydroxychloroquine (Plaquenil) is a medication used to treat rheumatoid arthritis, SLE and other rheumathological conditions.
Hydroxycholoquine toxicity can lead to eyesight damage, in absence of any other symptoms of toxicity. Significant amount of damage can occur before a person becomes aware of the problem. Hydroxychloroquine toxicity is relatively rare in the first five years of treatment but becomes more likely the longer someone is taking the medication or if they have other health problems.
It is important for all patients who are on this medication long term, to have an eye examination to detect possible signs of toxicity before the vision becomes affected.
We offer full ocular screening service in accordance with the latest guidelines published by Royal College of Ophthalmologists in 2018. These guidelines also state that hydroxychloroquine screening should be done by or under direct supervision of an ophthalmologist, rather than by independently practicing optometrists.